000284359 001__ 284359
000284359 005__ 20260130151313.0
000284359 0247_ $$2doi$$a10.1007/s00702-025-03062-3
000284359 0247_ $$2pmid$$apmid:41222710
000284359 0247_ $$2ISSN$$a0375-9245
000284359 0247_ $$2ISSN$$a0022-3026
000284359 0247_ $$2ISSN$$a0300-9564
000284359 0247_ $$2ISSN$$a1435-1463
000284359 037__ $$aDZNE-2026-00127
000284359 041__ $$aEnglish
000284359 082__ $$a610
000284359 1001_ $$0P:(DE-2719)2814178$$aFalkenburger, Björn$$b0$$udzne
000284359 245__ $$aClinical utility of digital technologies in Parkinson's disease.
000284359 260__ $$aWien [u.a.]$$bSpringer$$c2026
000284359 3367_ $$2DRIVER$$aarticle
000284359 3367_ $$2DataCite$$aOutput Types/Journal article
000284359 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1769782055_7436$$xReview Article
000284359 3367_ $$2BibTeX$$aARTICLE
000284359 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000284359 3367_ $$00$$2EndNote$$aJournal Article
000284359 520__ $$aDigital health technologies (DHTs) are on the verge of changing treatment of Parkinson's disease (PD). This narrative overview article describes DHTs that are already used or in development, focusing on technologies available in Germany and on their clinical utility. Examples include applications that are primarily used by patients, i.e., tools for patient education and empowerment, but also stand-alone interventions improving clinical outcomes including motor and non-motor symptoms. In Germany, these patient-centered DHTs fall under the HTA framework of digital health applications (DIGA). DHT for telemonitoring, in contrast, are designed to support physicians and other healthcare providers and therefore medical devices. DHT are also used increasingly as exploratory endpoints in trials testing neuroprotective treatments.
000284359 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000284359 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000284359 650_2 $$2MeSH$$aHumans
000284359 650_2 $$2MeSH$$aParkinson Disease: therapy
000284359 650_2 $$2MeSH$$aDigital Technology
000284359 650_2 $$2MeSH$$aTelemedicine
000284359 650_2 $$2MeSH$$aGermany
000284359 7001_ $$00000-0002-2854-4179$$aFanciulli, Alessandra$$b1
000284359 7001_ $$00000-0001-7680-2147$$aPötter-Nerger, Monika$$b2
000284359 7001_ $$0P:(DE-2719)2812285$$aEimeren, Thilo$$b3$$udzne
000284359 7001_ $$00000-0001-7182-6967$$aClassen, Joseph$$b4
000284359 7001_ $$0P:(DE-2719)2811373$$aHöglinger, Günter$$b5
000284359 7001_ $$00000-0001-7452-0525$$aRedecker, Christoph$$b6
000284359 7001_ $$aWinkler, Jürgen$$b7
000284359 7001_ $$00000-0001-6645-9437$$aKlucken, Jochen$$b8
000284359 773__ $$0PERI:(DE-600)1481655-6$$a10.1007/s00702-025-03062-3$$gVol. 133, no. 2, p. 297 - 307$$n2$$p297 - 307$$tJournal of neural transmission$$v133$$x0375-9245$$y2026
000284359 8564_ $$uhttps://pub.dzne.de/record/284359/files/DZNE-2026-00127.pdf$$yRestricted
000284359 8564_ $$uhttps://pub.dzne.de/record/284359/files/DZNE-2026-00127.pdf?subformat=pdfa$$xpdfa$$yRestricted
000284359 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2814178$$aExternal Institute$$b0$$kExtern
000284359 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2812285$$aExternal Institute$$b3$$kExtern
000284359 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811373$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000284359 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000284359 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-02$$wger
000284359 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-01-02$$wger
000284359 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEURAL TRANSM : 2022$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-02
000284359 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-02
000284359 9201_ $$0I:(DE-2719)1111015$$kClinical Research (Munich)$$lClinical Research (Munich)$$x0
000284359 980__ $$ajournal
000284359 980__ $$aEDITORS
000284359 980__ $$aVDBINPRINT
000284359 980__ $$aI:(DE-2719)1111015
000284359 980__ $$aUNRESTRICTED